These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6191469)

  • 1. [Course and stage control in testicular tumors using alpha 1-fetoprotein determination].
    Stadie G; Horn A; Schulze M; Flachsbart H; Schlichter W; Tscharnke J
    Z Urol Nephrol; 1983 Apr; 76(4):233-9. PubMed ID: 6191469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme immunoassay of alpha 1-fetoproteins in patients with testicular tumors].
    Schulze H; Schmechta H; Hallmann B; Ruttloff J; Porstmann T; Porstmann B
    Z Urol Nephrol; 1983 Mar; 76(3):137-44. PubMed ID: 6190326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha fetoprotein and dysgerminaomas].
    Bamert O; Grob PJ
    Schweiz Med Wochenschr; 1979 Dec; 109(49):1956-62. PubMed ID: 94180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 7. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)].
    Lamerz R; Staehler G; Hiermeyer L; von Lieven H
    Urologe A; 1977 Jul; 16(4):213-8. PubMed ID: 70876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of tumor markers in the diagnosis and follow-up of therapeutic effects in testicular tumors].
    Farkas L; Frang D; Csövári M; Pacsa S; Székely J
    Orv Hetil; 1984 Jul; 125(29):1747-51. PubMed ID: 6205348
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of serum alpha-1-fetoprotein studies in patients with testicular tumors receiving adjuvant and curative chemotherapy].
    Tóth I; Bodrogi I; Baki M; Eckhardt S
    Orv Hetil; 1983 Oct; 124(44):2661-8. PubMed ID: 6196706
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor markers in testicular germ cell tumors related to the stage of the disease at the time of diagnosis.
    Jacobsen GK
    Oncodev Biol Med; 1983; 4(6):C39-44. PubMed ID: 6196749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin - another tumor marker for testicular malignancies.
    Engelmann U; Büber V; Riedmiller H; Jacobi GH
    Eur Urol; 1981; 7(6):355-8. PubMed ID: 6169531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of alpha-fetoprotein by radioimmunoassay. Ten year experience in applying a locally produced kit.
    Nikolić JA; Stajić M; Argirović D
    Med Pregl; 1993; 46 Suppl 1():66-8. PubMed ID: 8569612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis].
    Canal P; Villeneuve G; Bugat R; Armand JP; Soula G
    Pathol Biol (Paris); 1984 Apr; 32(4):245-50. PubMed ID: 6201806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin and alphafetoprotein in the staging of nonseminomatous testicular cancer.
    Bosl GJ; Lange PH; Fraley EE; Goldman A; Nochomovitz LE; Rosai J; Waldmann TA; Johnson K; Kennedy BJ
    Cancer; 1981 Jan; 47(2):328-32. PubMed ID: 6161691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.